Government-Owned Inventions; Availability for Licensing, 79508 [2016-27222]

Download as PDF 79508 Federal Register / Vol. 81, No. 219 / Monday, November 14, 2016 / Notices for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301–435–0809, anna.ramseyewing@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: November 7, 2016. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–27223 Filed 11–10–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, HHS. ACTION: Notice. The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 209 and 37 CFR part 404 to achieve expeditious commercialization of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. FOR FURTHER INFORMATION CONTACT: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the National Heart, Lung and Blood Institute, Office of Technology Transfer and Development, National Institutes of Health, 31 Center Drive, Room 4A29, MSC2479, Bethesda, MD 20892–2479; telephone: 301–402–5579. A signed Confidential Disclosure Agreement may be required to receive copies of the patent applications. SUPPLEMENTARY INFORMATION: Technology descriptions follow. mstockstill on DSK3G9T082PROD with NOTICES SUMMARY: Immortalized Organ of Corti Cell Line OC-k3 Description of Technology Available for nonexclusive licensing as a research material is a conditionally immortalized Organ of Corti cell line called OC-k3. Sensory cells from the auditory organ, the Organ of Corti, are terminally differentiated and cannot be cultured. Moreover, few of them can be isolated per cochlea and survive only VerDate Sep<11>2014 17:26 Nov 10, 2016 Jkt 241001 few hours after isolation making impossible to use on them many biochemical and molecular biology techniques. OC-k3, expresses many markers of sensory cells and it has already been used as an in vitro model for a variety of studies. Potential Commercial Applications • Research • Hearing research • Susceptibility to ototoxic drugs Development Stage • Materials Inventors: Gilda Mabel Canseco de Kalinec and Federico Kalinec (both of NIDCD). Publications 1. Bertolaso L, et al. (2001) ‘‘Apoptosis in the OC-k3 immortalized cell line treated with different agents.’’ Audiology 40:327–335. PMID: 1178104637–5745. 2. Previati M, et al. (2007) ‘‘Cisplatin cytotoxicity in Organ of Corti-derived immortalized cells.’’ J Celt Biochem.101(5):1185–97, PMID: 7243113. Intellectual Property: HHS Reference No. E–012–2017/0—Research Material. Licensing Contact: Michael Shmilovich, Esq, CLP; 301–435–5019; shmilovm@mail.nih.gov. Dated: November 7, 2016. Michael Shmilovich, National Heart, Lung and Blood Institute, Office of Technology Transfer and Development, National Institutes of Health. [FR Doc. 2016–27222 Filed 11–10–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Office of the Secretary [Docket No. DHS–2016–0083] Privacy Act of 1974; Computer Matching Program U.S. Citizenship and Immigration Services, Department of Homeland Security. ACTION: Notice of Recertification. AGENCY: This document provides notice of the existence of a computer matching program between the Department of Homeland Security, U.S. Citizenship and Immigration Services and the New Jersey Department of Labor and Workforce Development, titled ‘‘Verification Division DHS–USCIS/NJ– LWD.’’ SUPPLEMENTARY INFORMATION: The Department of Homeland Security, U.S. SUMMARY: PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 Citizenship and Immigration Services provides this notice in accordance with the Privacy Act of 1974 (5 U.S.C. 552a), as amended by the Computer Matching and Privacy Protection Act of 1988 (Public Law 100–503) and the Computer Matching and Privacy Protection Amendments of 1990 (Public Law 101– 508) (Privacy Act); Office of Management and Budget (OMB) Final Guidance Interpreting the Provisions of Public Law 100–503, the Computer Matching and Privacy Protection Act of 1988, 54 FR 25818 (June 19, 1989); and appendix I to OMB’s Revision of Circular No. A–130 (November 28, 2000), ‘‘Transmittal Memorandum No. 4, Management of Federal Information Resources.’’ Participating Agencies: The Department of Homeland Security, U.S. Citizenship and Immigration Services (DHS–USCIS) is the source agency and the New Jersey Department of Labor and Workforce Development (NJ–LWD) is the recipient agency. Purpose of the Match: The purpose of this Agreement is to establish the terms and conditions governing NJLWD’s access to, and use of, the DHS–USCIS Systematic Alien Verification for Entitlements (SAVE) Program, which provides immigration status information from Federal immigration records to authorized users, and to comply with the Computer Matching and Privacy Protection Act of 1988. New Jersey Department of Labor and Workforce Development will use the SAVE Program to verify the immigration status of non U.S. citizens who apply for benefits (Benefit Applicants) under the Unemployment Compensation (UC) benefits that it administers. Under Federal law, immigrant workers must be in particular immigration categories to qualify for UC benefits. NJLWD will use the information obtained through the SAVE Program to determine whether Benefit Applicants possess the requisite immigration status to be eligible for the UC benefits administered by NJLWD. Authority for Conducting the Matching Program: Section 121 of the Immigration Reform and Control Act (IRCA) of 1986, Public Law 99–603, as amended by the Personal Responsibility and Work Opportunity Reconciliation Act of 1996 (PRWORA), Public Law 104–193, 110 Stat. 2168 (1996), requires DHS to establish a system for the verification of immigration status of alien applicants for, or recipients of, certain types of benefits as specified within IRCA, and to make this system available to state agencies that administer such benefits. Section 121(c) of IRCA amends sec. 1137 of the Social Security Act and certain other sections E:\FR\FM\14NON1.SGM 14NON1

Agencies

[Federal Register Volume 81, Number 219 (Monday, November 14, 2016)]
[Notices]
[Page 79508]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-27222]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S. in accordance 
with 35 U.S.C. 209 and 37 CFR part 404 to achieve expeditious 
commercialization of federally-funded research and development. Foreign 
patent applications are filed on selected inventions to extend market 
coverage for companies and may also be available for licensing.

FOR FURTHER INFORMATION CONTACT: Licensing information and copies of 
the U.S. patent applications listed below may be obtained by writing to 
the indicated licensing contact at the National Heart, Lung and Blood 
Institute, Office of Technology Transfer and Development, National 
Institutes of Health, 31 Center Drive, Room 4A29, MSC2479, Bethesda, MD 
20892-2479; telephone: 301-402-5579. A signed Confidential Disclosure 
Agreement may be required to receive copies of the patent applications.

SUPPLEMENTARY INFORMATION: Technology descriptions follow.

Immortalized Organ of Corti Cell Line OC-k3 Description of Technology

    Available for nonexclusive licensing as a research material is a 
conditionally immortalized Organ of Corti cell line called OC-k3. 
Sensory cells from the auditory organ, the Organ of Corti, are 
terminally differentiated and cannot be cultured. Moreover, few of them 
can be isolated per cochlea and survive only few hours after isolation 
making impossible to use on them many biochemical and molecular biology 
techniques. OC-k3, expresses many markers of sensory cells and it has 
already been used as an in vitro model for a variety of studies.

Potential Commercial Applications

 Research
 Hearing research
 Susceptibility to ototoxic drugs

Development Stage

 Materials
    Inventors: Gilda Mabel Canseco de Kalinec and Federico Kalinec 
(both of NIDCD).

Publications

    1. Bertolaso L, et al. (2001) ``Apoptosis in the OC-k3 immortalized 
cell line treated with different agents.'' Audiology 40:327-335. PMID: 
1178104637-5745.
    2. Previati M, et al. (2007) ``Cisplatin cytotoxicity in Organ of 
Corti-derived immortalized cells.'' J Celt Biochem.101(5):1185-97, 
PMID: 7243113.
    Intellectual Property: HHS Reference No. E-012-2017/0--Research 
Material.
    Licensing Contact: Michael Shmilovich, Esq, CLP; 301-435-5019; 
shmilovm@mail.nih.gov.

    Dated: November 7, 2016.
Michael Shmilovich,
National Heart, Lung and Blood Institute, Office of Technology Transfer 
and Development, National Institutes of Health.
[FR Doc. 2016-27222 Filed 11-10-16; 8:45 am]
 BILLING CODE 4140-01-P